CANSINO BIOLOGICS INC revenue breakdown overview

CANSINO BIOLOGICS INC revenue for the last year amounted to 48.62 M USD, the most of which — 50.52 M USD — came from its highest performing source at the moment, Vaccine Products, the year earlier bringing 154.01 M USD. The greatest contribution to the revenue figure was made by China — last year it brought CANSINO BIOLOGICS INC 48.39 M USD, and the year before that — 120.99 M USD.